Clinical Trial Update: Safety Study of Mesenchymal Stem Cells and Spinal Fusion [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety of mesenchymal stem cells in spinal fusion (Phase 1/2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Discopathy Involving L4-l5
• Lumbar Spondylolisthesis Involving L4-l5

Snippet

Sponsor: Banc de Sang i Teixits | Conditions: Lumbar Spondylolisthesis Involving L4-L5, and/or, Degenerative Discopathy Involving L4-L5 | Phase 1, Phase 2 | Status: COMPLETED